Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FUTIBATINIB vs GADOPICLENOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FUTIBATINIB vs GADOPICLENOL: Safety Overview

Metric FUTIBATINIB GADOPICLENOL
Total FAERS Reports 161 148
Deaths Reported 38 0
Death Rate 23.6% N/A
Hospitalizations 60 10
Average Patient Age 61.8 yrs 47.7 yrs
% Female Patients 51.3% 66.9%
FDA Approval Date Jul 28, 2025 Sep 21, 2022
Manufacturer TAIHO PHARMACEUTICAL CO., LTD. Guerbet LLC
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription